Mark Foley is the CEO of Revance, a company known for its innovative aesthetic and therapeutic products. With over 25 years of experience in the healthcare sector, Foley has previously led ZELTIQ Aesthetics through significant growth and transformation.
Mark Foley's Email & LinkedIn
You can also contact Mark Foley through his LinkedIn.
If you want to find further information about Mark Foley, like his phone number, or other people working at Revance, sign up to Clay.
Who is the CEO of Revance?
Mark Foley, the CEO of Revance, brings a wealth of experience from various senior roles in the healthcare industry. Before joining Revance, he held leadership positions at U.S. Surgical Corporation, Guidant Corporation, and Devices for Vascular Intervention, among others. Foley also founded Ventrica, which was later acquired by Medtronic. His tenure at ZELTIQ Aesthetics saw the company’s revenue soar and its eventual acquisition by Allergan.
At Revance, Foley is steering the company towards the successful launch of DaxibotulinumtoxinA for Injection and exploring new therapeutic applications.
Work History
Mark Foley's extensive work history showcases his leadership across various companies in the healthcare and aesthetic sectors. Here is a detailed list of his previous roles:
- Revance Therapeutics, Inc. - Chief Executive Officer (2019 to Present)
- Revance Therapeutics, Inc. - Board Member (2017 to Present)
- ULab - Chairman (2015 to Present)
- Glaukos Corporation - Board Member (2014 to Present)
- Aesthetic Innovation Summit - Co-Chair of the Aesthetic Innovation Summit (AIS) (2017 to 2020)
- RWI Ventures - Managing Director (2004 to 2018)
- ZELTIQ - Chairman, President & CEO (2012 to 2017)
- Onpharma - Executive Chairman (2009 to 2014)
Education History
Mark Foley's educational background includes a Bachelor's Degree from the University of Notre Dame, where he studied from January 1983 to January 1987. This foundational education set the stage for his extensive career in the healthcare and aesthetic sectors, providing him with the knowledge and skills necessary to lead and innovate in various high-profile roles.
When did Mark Foley join Revance?
Mark Foley joined Revance Therapeutics, Inc. as a Board Member on September 1, 2017, and later became the Chief Executive Officer on October 1, 2019. With his extensive background in the healthcare sector, Foley has been instrumental in steering the company towards new heights.
As of now, he has been with Revance for over six years, contributing significantly to its growth and strategic direction.